Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model
نویسندگان
چکیده
Alanna Coolong, Donald S. Baim, Richard E. Kuntz, A. James O'Malley, Sachin Marulkar, Derived From a Pooled Analysis of 3958 Patients Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2008 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/CIRCULATIONAHA.106.651232 2008;117:790-797; originally published online January 22, 2008; Circulation. http://circ.ahajournals.org/content/117/6/790 World Wide Web at: The online version of this article, along with updated information and services, is located on the
منابع مشابه
Long-term outcomes of saphenous vein graft stenting compared with native coronary artery stenting in patients with previous coronary artery bypass graft surgery.
OBJECTIVE Our main objective was to compare the in-hospital and long-term outcomes of saphenous vein graft stenting and native coronary artery stenting in patients with previous coronary artery bypass grafting. METHODS We studied 127 patients who had prior coronary artery bypass; they were divided in two groups, according to the kind of percutaneous coronary intervention performed. The first ...
متن کاملEarly and Midterm Major Adverse Cardiac Events in Patient With Saphenous Vein Graft Using Direct Stenting or Embolic Protection Device Stenting
BACKGROUND The treatment of an occluded saphenous vein graft (SVG) with percutaneous coronary intervention may encounter major adverse cardiac events (MACE). MACE rates have been reduced significantly by using the embolic protection device (EPD). OBJECTIVES The aim of this study was to clarify the risks and the benefits of embolic protection devices. PATIENTS AND METHODS In a prospective, n...
متن کاملRegulatory perspective on embolic protection device approval for saphenous vein graft stenting with a single-arm trial using risk-adjusted prediction model.
The article by Coolong et al1 in this issue of Circulation identifies potential predictors of 30-day major adverse cardiac events (MACE) after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection devices (EPDs). These predictors, angiographic estimates of plaque volume and SVG degeneration, were derived from patient-level data on 3958 patients enrolled in ...
متن کاملEmbolic protection during saphenous vein graft intervention using a second-generation balloon protection device: results from the combined US and European pilot study of the TriActiv Balloon Protected Flush Extraction System.
BACKGROUND Stent placement in saphenous vein bypass grafts is associated with a high incidence of myonecrosis usually resulting from embolization of thrombus and friable atheroma. Embolic protection devices reduce the incidence of adverse events after vein graft stenting. However, first-generation balloon occlusion systems are still associated with a 10% incidence of periprocedural adverse even...
متن کاملSaphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients.
BACKGROUND Treatment of saphenous vein graft (SVG) stenosis with percutaneous coronary intervention has a 15% to 20% incidence of major adverse cardiac events (MACE) within 30 days. Although MACE rates are reduced significantly by the use of embolic protection devices (EPDs), neither the level of baseline risk nor the benefit provided by EPDs has been well characterized. METHODS AND RESULTS D...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2008